GEODE CAPITAL MANAGEMENT, LLC
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ABOS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$982,320
+$116,786 QoQ
Shares Held
416,238
+1.5% QoQ
Ownership
0.576%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 84 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,556,460,669 across 523 Biotechnology names. ABOS ranks #313 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ABOS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $982,320 | 416,238 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $865,534 | 410,206 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $681,909 | 398,778 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $460,085 | 396,626 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $948,088 | 861,899 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,497,354 | 870,555 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,144,028 | 864,528 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,965,361 | 812,133 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,154,812 | 285,139 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,016,075 | 264,603 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,098,102 | 264,603 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $802,404 | 166,820 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $677,289 | 166,820 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $900,828 | 166,820 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,581,179 | 157,645 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $511,590 | 108,849 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,339,745 | 342,646 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,161,902 | 171,879 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,601,997 | 107,806 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||